Charles Skinner Hallpike
Charles Skinner Hallpike | |
|---|---|
| Born | 19 July 1900 Murree, British India |
| Died | 26 September 1979 |
| Nationality | British |
| Known for | Hallpike test, Ménière's disease research |
| Scientific career | |
| Fields | Otology, Neurology |
Charles Skinner Hallpike (19 July 1900 – 26 September 1979) was a prominent British otologist and neurologist, renowned for his pioneering work in the field of vestibular system disorders. He is best known for developing the Dix-Hallpike test, a diagnostic maneuver used to identify benign paroxysmal positional vertigo (BPPV).
Early Life and Education[edit | edit source]
Charles Hallpike was born in Murree, British India, and later moved to England where he pursued his education. He attended University College London and subsequently trained in medicine at St Bartholomew's Hospital, London. Hallpike's early interest in the nervous system and ear anatomy led him to specialize in otology and neurology.
Career and Research[edit | edit source]
Hallpike's career was marked by significant contributions to the understanding of inner ear disorders. He worked extensively on the pathology and treatment of Ménière's disease, a condition characterized by episodes of vertigo, tinnitus, and hearing loss. His research provided insights into the endolymphatic hydrops theory, which suggests that the symptoms of Ménière's disease are due to an abnormal accumulation of fluid in the inner ear.
In collaboration with Dr. Margaret Dix, Hallpike developed the Dix-Hallpike test, a clinical test used to diagnose BPPV. This test involves the patient being rapidly moved from a sitting to a supine position with the head turned 45 degrees to one side, which can provoke vertiginous symptoms and nystagmus if BPPV is present.
Legacy[edit | edit source]
Hallpike's work has had a lasting impact on the fields of otology and neurology. The Dix-Hallpike test remains a cornerstone in the diagnosis of vestibular disorders. His contributions to the understanding of Ménière's disease have paved the way for further research and improved treatment options for patients suffering from this debilitating condition.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
